-
Dr Maria Rubio awarded a scientific excellence grant from the European Research Council (ERC)
This financial award will fund an intervention in several primary care centres in Catalonia and is designed to encourage people with diabetes and cardiovascular disease to begin and comply with the pharmacological treatments as prescribed by their physician.
-
Reproduce various stages of Ewing's sarcoma in mice
Researchers at Institut de Recerca Sant Joan de Déu reproduce various stages of Ewing's sarcoma in mice to explain its resistance to medication.
-
The european ImmunAID project starts its clinical phase
The ImmunAID project aims to develop new diagnostic signatures for systemic auto-inflammatory diseases (SAID). Ultimately, the aim is to offer better care for these rare disease patients. Systemic auto-inflammatory diseases (SAID) are a complex and poorly understood group of rare diseases.
-
Gate2Brain, the “key” to transporting drugs into the brain and improving their effectiveness
Gate2Brain technology is based on a research line developed at IRB Barcelona and breakthroughs made jointly with the University of Barcelona and the Institut de Recerca Sant Joan de Déu - SJD Barcelona Children’s Hospital.
-
Care robotics can help patients with Duchenne muscular dystrophy (DMD)
An IRSJD research team develop a robotic wheelchair helps to improve the physical condition of people with Duchenne muscular dystrophy.
-
Kids Corona Project presents the preliminary results
A study made by SJD Barcelona Children's Hospital · Instritut de Recerca Sant Joan de Déu reveals that 17% of children who have had contact with a sick person have become infected. Children have a similar prevalence of COVID-19 antibodies to adults, but more than 99% have mild symptoms.
-
A genomic analysis in samples of Neanderthals and modern humans shows a decrease in ADHD-associated genetic variants
The frequency of genetic variants associated with attention-deficit/hyperactivity disorder (ADHD) has decreased progressively in the evolutionary human lineage from the Palaeolithic to nowadays, according to a study published in the journal Scientific Reports.
-
Sant Joan de Déu begins four lines of research for the study of COVID-19
Researchers from the Sant Joan de Déu Research Institute and the Sant Joan de Déu Barcelona Children's Hospital are starting four projects to study COVID19 from a microbiological and clinical perspective with regard to inflammatory and maternal-foetal response. To do so, they need to recruit 500 families with children in which at least one adult has tested positive.
-
The importance of time in the treatment of Rett Syndrome
The research team led by Dr Àngels García-Cazorla (IRSJD) has broken new ground in improving the treatment of Rett Syndrome. Researchers at the Sant Joan de Déu Research Institute (IRSJD) and the Bellvitge Biomedical Research Institute (IDIBELL) have found that early GABAergic modulation may offer a promising strategy for affected children.
